| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $512.1M | +18.8% |
| Cost of Revenue | $181.0M | +41.2% |
| Gross Profit | $331.1M | +9.4% |
| R&D Expense | $25.9M | +36.3% |
| SG&A Expense | $332.6M | +30.8% |
| Operating Income | -$251.0M | -2181.5% |
| Pre-tax Income | -$263.9M | -3563.2% |
| Income Tax | -$50.5M | -2469.1% |
| Net Income | -$158.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.8M | -27.6% |
| Accounts Receivable | $136.6M | +9.3% |
| Inventory | $85.4M | +38.5% |
| Current Assets | $272.6M | +3.6% |
| Total Assets | $1.37B | +12.0% |
| Current Liabilities | $304.0M | +68.1% |
| Long-term Debt | $385.0M | +7.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | -158.9% |
| Capital Expenditures | $10.0M | +36.3% |
| Investing Cash Flow | -$116.4M | +59.0% |
| Financing Cash Flow | $62.1M | -77.3% |
| Free Cash Flow | -$23.6M | -250.9% |
| -919.1% |
| EPS (Basic) | -$2.59 | -1626.7% |
| EPS (Diluted) | -$2.59 | -1626.7% |
| Total Liabilities |
| $1.03B |
| +49.2% |
| Stockholders' Equity | $316.6M | -31.0% |